Express Pharma - Express Pharma

Rating recognises transparent management of CO2 emissions

Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action

Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…

The parties will seek dismissal of the pending LEQSELVI litigation in the United States District Court for the District of New…

Durvalumab in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Durvalumab as adjuvant…

The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…

Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has expressed urgent concerns over the recent circular issued…

After 50 years of LAL testing, the pharmaceutical industry is transitioning to recombinant Factor C (rFC) methods. USP Chapter…